BEAT Richard Brounstein buys $0 worth of shares
Jan 04, 2026, 5:45 AM
-6.81%
What does BEAT do
HeartBeam, a development stage company based in Santa Clara, California, focuses on advanced cardiovascular diagnostic technology and went public on October 14, 2021. They are developing proprietary VECG technology and two patented products, HeartBeam AIMI and HeartBeam AIMIGo, for cardiac disease detection and monitoring.
Richard Brounstein bought 10,000 shares of BEAT on 30 March at $0.00 per share, worth a total of $0. They now own 10,000 BEAT shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.